About Andrew Katz
Form D filings for Mid-Atlantic BioTherapeutics in 2024 list Andrew Katz as director.
Andrew Katz first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Katz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Katz works with at each company, as listed on that company's latest Form D.
Mid-Atlantic BioTherapeutics, Inc. · Form D, Sep 30, 2024
JC
Julian Chick
Director
DH
David Horn
Chief Executive Officer and director
MG
Michael Goldblatt
Director
DJ
David Jobes
President and director
JG
Jean Pierre Gagnon
Director